Compare Brevis (BREV) vs Mitosis (MITO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brevis vs Mitosis — how do they compare? Brevis trades at Rp1,209 (market cap Rp302,13M, Rp167,76M 24h volume), while Mitosis trades at Rp465.62 (market cap Rp84,62M, Rp77,56M 24h volume). The key difference: Brevis is far larger — about 3.6× Mitosis's market cap, and Brevis's circulating supply is 250M / 1B BREV (25%) versus 181,3M / 1B MITO (19%) for Mitosis. Which is the better fit depends on your goals — on Pluang, investors hold Brevis for 8 Days and Mitosis for 20 Days on average.
| BREV | MITO | |
|---|---|---|
Market Cap | Rp302,13M | Rp84,62M |
Volume (24h) | Rp167,76M | Rp77,56M |
Circulating Supply | 250M / 1B BREV (25%) | 181,3M / 1B MITO (19%) |
Typical Hold Time | 8 Days | 20 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Brevis (BREV) is trading at Rp1,215.88 with a market cap of Rp304.38 million, showing a bearish technical signal as moving averages indicate strong selling pressure while oscillators remain neutral. The current price sits just below the pivot point of Rp1,219, with immediate support at Rp1,203 and resistance at Rp1,237. No recent protocol updates or ecosystem news are available, and the token has a low circulation rate of 25% with a max supply of 1 million tokens.
Overall outlook is cautious due to bearish technicals and limited liquidity. Key opportunities include potential rebounds from oversold RSI levels, but major risks involve low trading volume, high volatility, and lack of recent development activity, making it susceptible to price swings.
MITO is trading at Rp450.11 with a market cap of Rp81.9M, showing bullish technical signals across moving averages and oscillators. The token is currently trading near the pivot point of Rp445 with resistance at Rp464 and support at Rp429. With a circulating supply of 181,300 tokens (19% of max supply) and average hold time of 20 days, the token shows moderate network activity.
Overall outlook remains cautiously bullish with technical indicators supporting upward momentum, though RSI levels suggest potential overbought conditions. Key opportunities include strong technical positioning, while risks include low liquidity and regulatory uncertainty in the crypto space.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Brevis
Brevis is a verifiable computing platform that enables scalable, trustless computation across blockchain, data, and AI systems. It allows complex programs and data queries to run off-chain and be verified on-chain using zero-knowledge proofs, delivering significantly lower costs and latency while preserving security and trustlessness.
Read more on BREV →About Mitosis
Mitosis is a cross-chain DeFi protocol that converts liquidity positions into programmable and composable assets. It tackles two significant inefficiencies in decentralized finance: the illiquidity of staked assets and limited access to high-yield opportunities for smaller users.
Read more on MITO →
